Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Renal Cell Carcinoma ( mRCC)”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Testing effectiveness (Phase 2)Study completedNCT00556049
What this trial is testing

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaNeoplasm Metastases
Massachusetts General Hospital 72
Testing effectiveness (Phase 2)Study completedNCT03967522
What this trial is testing

Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases

Who this might be right for
Metastatic Renal Cell Carcinoma
Centre Leon Berard 26
Testing effectiveness (Phase 2)Study completedNCT02599779
What this trial is testing

A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients

Who this might be right for
Stage IV Renal Cell Cancer AJCC V7
Sunnybrook Health Sciences Centre 4
Testing effectiveness (Phase 2)Study completedNCT03469713
What this trial is testing

Nivolumab Plus Stereotactic Body Radiotherapy in II and III Line of Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cancer Metastatic
Gruppo Oncologico Italiano di Ricerca Clinica 69
Early research (Phase 1)Study completedNCT04540705
What this trial is testing

Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 30
Large-scale testing (Phase 3)Study completedNCT01223027
What this trial is testing

Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Novartis Pharmaceuticals 564
Testing effectiveness (Phase 2)UnknownNCT02324803
What this trial is testing

Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients

Who this might be right for
Self EfficacyAdverse Drug EventCarcinoma, Renal Cell
Southern China Urology Cancer Consortium 86
Testing effectiveness (Phase 2)Ended earlyNCT01342627
What this trial is testing

Sorafenib in Elderly Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Centro di Riferimento Oncologico - Aviano 4
Testing effectiveness (Phase 2)Study completedNCT01767636
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Carcinoma of the Collecting Ducts of BelliniChromophobe Renal Cell CarcinomaKidney Medullary Carcinoma+6 more
Mayo Clinic 38
Early research (Phase 1)Study completedNCT01482156
What this trial is testing

Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Breast CancerMetastatic Renal Cell Carcinoma
Novartis Pharmaceuticals 46
Not applicableNot Yet RecruitingNCT07233668
What this trial is testing

Immediate Versus Deferred Cytoreductive Nephrectomy With Ipilimumab/Nivolumab in mRCC

Who this might be right for
Metastatic Renal Cell Carcinoma ( mRCC)
Seoul National University Hospital 172
Testing effectiveness (Phase 2)Ended earlyNCT03456401
What this trial is testing

Third Line TKI After 2 TKIs in Patients With mRCC (Tokio Study)

Who this might be right for
Renal Cancer Cell
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 18
Not applicableStudy completedNCT00842790
What this trial is testing

Impact of Predicting Anti-angiogenic Response in mRCC Using Functional Imaging

Who this might be right for
Carcinoma, Renal Cell
Assistance Publique - Hôpitaux de Paris 107
Not applicableStudy completedNCT01598597
What this trial is testing

An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)

Who this might be right for
Breast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more
Genentech, Inc. 276
Early research (Phase 1)UnknownNCT02577458
What this trial is testing

Study of the Combination of CM082 With Everolimus in Patients With mRCC

Who this might be right for
Renal Cell Carcinoma Recurrent
AnewPharma 18
Not applicableStudy completedNCT05363072
What this trial is testing

Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.

Who this might be right for
Renal Cell CancerRenal Cell CarcinomaCancer of Kidney+4 more
Pfizer 1,112
Testing effectiveness (Phase 2)Ended earlyNCT02447887
What this trial is testing

Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC)

Who this might be right for
Metastatic Renal Cell CarcinomaRCC
Fox Chase Cancer Center 3
Early research (Phase 1)Active Not RecruitingNCT05479812
What this trial is testing

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Werewolf Therapeutics, Inc. 150
Not applicableStudy completedNCT04669366
What this trial is testing

Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries

Who this might be right for
Kidney Neoplasms
Pfizer 1,205
Testing effectiveness (Phase 2)Study completedNCT02060370
What this trial is testing

Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)

Who this might be right for
Genitourinary CancerKidney Cancer
M.D. Anderson Cancer Center 60
Load More Results